-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.AUD↓
Zahlte zuletzt am 12.04.2010 eine Dividende von 0,009 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Dir gefallen die Informationen zu IDT Australia Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu IDT Australia Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu IDT Australia Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu IDT Australia Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
30 News & Informationen zur IDT Australia Limited Aktie
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs for ASX health stocks.
Hot Money Monday: ASX large caps run hot in a bumper earnings season
Hot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger companies near the top end of the list.
Closing Bell: ASX closes slightly lower, still notches up weekly gain
Closing Bell: ASX closes slightly lower, still notches up weekly gain
Weekly ASX small cap wrap: Local stocks look to get back on the horse as the Fed looms
The ASX got back in the saddle to some extent this week, after a mid-August iron ore price rout that flowed through to double-digit percentage falls for the big miners.
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana
The biggest weed winner on the ASX this week was IDT Australia (ASX:IDT) up 36% off the back of news it managed to turn its FY20 loss into a profit in FY21.
IDT Australia (ASX:IDT) reports first operating profit since 2009
Over the 2021 financial year, IDT Australia (ASX:IDT) recorded its first operating profit since 2009.
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
ASX biotech stock Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with focal segmental glomerulosclerosis (FSGS).
Closing Bell: After last week’s losing run, the ASX has returned to growth
Closing Bell: After last week’s losing run, the ASX has returned to growth
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
IDT Australia jumped more than 20% after announcing that it has formalised activities with the Australian Government to assist with COVID-19 vaccine.
10 at 10: These ASX stocks are the first to shine this morning
10 at 10: These ASX stocks are the first to shine this morning
Hot Money Monday: BNPL gets the shivers, while Ikwezi Mining runs hot as coal makes a comeback
After two straight weeks where lithium stocks dominated the Running Hot list, this week's list was led by coal stock Ikwezi Mining (ASX:IKW).
Closing Bell: ASX down 2.2pc for the week
Closing Bell: ASX down 2.2pc for the week
Weekly ASX small cap wrap: Iron ore pulls the market down after jumping off a cliff
Weekly ASX small cap wrap: Iron ore pulls the market down after jumping off a cliff
ASX Cannabis Stocks Guide 2021: Here’s everything you need to know
Read the ultimate guide on ASX cannabis stocks, companies and pricing. Gain advice to uncover market conditions and investing opportunities.
ASX Small Cap Lunch Wrap: Who’s lighting landmarks purple today?
ASX Small Cap Lunch Wrap: Who’s lighting landmarks purple today?
Closing Bell: ASX retreats for the third day in a row
Closing Bell: ASX retreats for the third day in a row
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
Massachusetts based MariMed has just announced a joint collaboration with a legendary ice cream brand to create a line-up of cannabis-infused ice cream.
Trading Places: Who’s betting on return to office stocks?
ASX fund managers are buying return to office stocks such as ServCorp (ASX:SRV) which operates services offices and is tipping people will return.
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the benchmark rose by 3%.
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores
The Community College of Denver has just launched a cannabis business program in Colorado. Yes, we're talking about cannabis degrees.
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Technicorum Holdings announced The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market.
Investors have struggled to find long term money makers from COVID, but has this sector been the one all along?
ASX investors have long looked for stocks that will benefit from COVID-19 in the long term. But potentially pathology stocks may offer that opportunity.
Rise and Shine: What you need to know before the ASX opens
The 'best value' gold stock on the ASX, how to shake off market jitters, and Stockhead's own 'Dragon's Den'.
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
Stockhead reports ASX biotech and healthcare roundup for the last fortnight. Stocks include Actinogen (ACW), Suda Pharma (SUD), and Patrys (PAB).
Closing Bell: Today’s biggest small cap movers on the ASX
Closing Bell: Today’s biggest small cap movers on the ASX
ASX Small Cap Lunch Wrap: Clear and very real present danger
'Rona is back with a bang in NSW, after authorities flagged another 16 new COVID-19 cases over the past 24 hours.
10 at 10: These ASX stocks have given shareholders something to cheer about this morning
10 at 10: These ASX stocks have given shareholders something to cheer about this morning
Why the IDT Australia (ASX:IDT) share price is storming 19% higher today
The IDT Australia Limited (ASX:IDT) share price is storming 19% higher on Tuesday. Here's why investors have been buying its shares…